María José
Larráyoz Ilundáin
Clínico Asociado
Julen
Oyarzabal Santamarina
Forscher bis um 2018
Publikationen, an denen er mitarbeitet Julen Oyarzabal Santamarina (2)
2024
-
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Nature Communications, Vol. 15, Núm. 1
2021
-
Endogenous retroelement activation by epigenetic therapy reverses the warburg effect and elicits mitochondrial-mediated cancer cell death
Cancer Discovery, Vol. 11, Núm. 5, pp. 1268-1285